HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

polyethylbutylcyanoacrylate

structure in first source

Also Known As:

PEBCA

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Engebråten, Olav: 1 article (04/2021)
2.	Grinde, Maria T: 1 article (04/2021)
3.	Iversen, Tore-Geir: 1 article (04/2021)
4.	Kildal, Wanja: 1 article (04/2021)
5.	Moestue, Siver: 1 article (04/2021)
6.	Mælandsmo, Gunhild M: 1 article (04/2021)
7.	Mørch, Ýrr: 1 article (04/2021)
8.	Pandya, Abhilash D: 1 article (04/2021)
9.	Sandvig, Kirsten: 1 article (04/2021)
10.	Skotland, Tore: 1 article (04/2021)

Related Diseases

1.	Neoplasms (Cancer) 04/28/2021 - "High-resolution magic angle spinning magnetic resonance (HR MAS MR) spectroscopy did not reveal any differences in the metabolic profiles of tumors following injection of the NPs, but the PEBCA NPs resulted in higher tumor infiltration of the anti-tumorigenic M1 macrophages than obtained with the two other NPs. " 04/28/2021 - "The PEBCA NPs had the highest uptake both in the patient-derived breast cancer xenograft MAS98.12 and in lymph nodes, and therefore, they are the most promising of these NPs for delivery of cancer drugs. " 04/28/2021 - "The PEBCA NPs also increased the ratio of M1/M2 (anti-tumorigenic/pro-tumorigenic) macrophages in the tumors, suggesting that these NPs might be used both as a vehicle for drug delivery and to modulate the immune response in favor of enhanced therapeutic effects." 04/28/2021 - "We have investigated the biodistribution and tumor macrophage infiltration after intravenous injection of the poly(alkyl cyanoacrylate) nanoparticles (NPs): PEBCA (poly(2-ethyl-butyl cyanoacrylate), PBCA (poly(n-butyl cyanoacrylate), and POCA (poly(octyl cyanoacrylate), in mice. "
2.	Breast Neoplasms (Breast Cancer) 04/28/2021 - "The PEBCA NPs had the highest uptake both in the patient-derived breast cancer xenograft MAS98.12 and in lymph nodes, and therefore, they are the most promising of these NPs for delivery of cancer drugs. "

Related Drugs and Biologics

1.	Therapeutic Uses
2.	Enbucrilate
3.	Cyanoacrylates
4.	octyl 2-cyanoacrylate
5.	ethyl 2- (5- (4- chlorophenyl)pentyl)oxiran- 2- carboxylate (POCA)

Related Therapies and Procedures

1.	Intravenous Injections